45th Multicenter Airway Research Collaboration

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

1,860

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Asthma AcuteAsthma ExacerbationAsthmaAsthma Control Level

Interventions

DRUG

Airsupra

1 dose (2 inhalations) PRN, with maximum of 6 doses (12 inhalations) in a 24-hour period

Trial Locations (1)

MetroHealth, Cleveland

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER